1-3 of 3
Shambhavi Kumar, MS
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Thrombotic Events and Mortality Risk in Patients Newly Diagnosed with Intermediate- to High-Risk Essential Thrombocythemia in the United States

Naveen Pemmaraju, MD, Aaron T. Gerds, MDMS, Jingbo Yu, MD PhD, Shreekant Parasuraman, BPharm, PhD, Anne Shah, Ann Xi, PharmD, Shambhavi Kumar, MS, Robyn M. Scherber, MD, Srdan Verstovsek, MD PhD
Journal: Blood
Blood (2020) 136 (Supplement 1): 21.
https://doi.org/10.1182/blood-2020-141333
Published: 2020
Journal Articles

Thrombosis and Risk of Mortality in Newly Diagnosed High-Risk Polycythemia Vera: An Analysis of the Medicare Claims Database in the United States

Naveen Pemmaraju, MD, Aaron T. Gerds, MDMS, Shreekant Parasuraman, BPharm, PhD, Jingbo Yu, MD PhD, Anne Shah, Ann Xi, PharmD, Shambhavi Kumar, MS, Robyn M. Scherber, MD, Srdan Verstovsek, MD PhD
Journal: Blood
Blood (2020) 136 (Supplement 1): 9–10.
https://doi.org/10.1182/blood-2020-141370
Published: 2020
Journal Articles

Real-World Survival Among Patients with Intermediate- to High-Risk Myelofibrosis in the United States: Impact of Ruxolitinib Approval

Srdan Verstovsek, MD PhD, Shreekant Parasuraman, BPharm, PhD, Jingbo Yu, MD PhD, Anne Shah, Shambhavi Kumar, MS, Ann Xi, PharmD, Claire Harrison, DM, FRCP, FRCPath
Journal: Blood
Blood (2020) 136 (Supplement 1): 46–47.
https://doi.org/10.1182/blood-2020-140820
Published: 2020